Recent advances in non-small cell lung cancer biology and clinical management.
about
Autophagy and radiosensitization in cancerHow bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public healthProtein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients.The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club.New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib.LRIG2 expression and prognosis in non-small cell lung cancer.Cytotoxic autophagy in cancer therapy.PI3K Inhibition Augments the Therapeutic Efficacy of a 3a-aza-Cyclopenta[α]indene Derivative in Lung Cancer CellsWhole DNA methylome profiling in lung cancer cells before and after epithelial-to-mesenchymal transition.Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas.CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisIn vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cellsThe intricate role of CXCR4 in cancer.Pazopanib diminishes non-small cell lung cancer (NSCLC) growth and metastases in vivoNext-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on AfatinibExpression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089.Association of chemokine and chemokine receptor expression with the invasion and metastasis of lung carcinomaReduced expression of sushi domain containing 2 is associated with progression of non-small cell lung cancerCXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.Erlotinib resistance in lung cancer: current progress and future perspectives.Effects of green-synthesized silver nanoparticles on lung cancer cells in vitro and grown as xenograft tumors in vivoMechanisms of resistance to EGFR targeted therapies.Chemokines and their receptors in lung cancer progression and metastasis.Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1 (TGF-β1) during thoracic radiotherapy are predictive for radiation pneumonitisExpression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer.Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cellsRadiotherapy response evaluation using FDG PET-CT-established and emerging applications.Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancerRecruitment of CD11b+Ly6C+ monocytes in non-small cell lung cancer xenografts challenged by anti-VEGF antibody.Enhancement of Proliferation and Invasion of Gastric Cancer Cell by KDM5C Via Decrease in p53 Expression.Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer.Oncogene-Driven Metabolic Alterations in Cancer.Is %ΔSUVmax a useful indicator of survival in patients with advanced nonsmall-cell lung cancer?Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells
P2860
Q26865330-DDE26781-B9D5-4F77-B51A-3D293CBE73CFQ28649612-73C754C5-92BD-4AE1-BA81-2A2593A30234Q30432789-AC86AC77-977C-4602-B5E8-00C48D8398F2Q33658238-B56412DD-D215-48B3-A305-0D54CC92749DQ33704088-B5AB4E4F-78C5-405C-87E8-8FC91EDAA6DFQ33844052-B503C03A-2D90-463D-AACE-9FE663C97449Q33907663-2BBC6B4E-CD88-470D-86BA-3C8202C641EEQ33912340-F5D79FA4-7A71-4D0A-833E-3EA4F0520DADQ33938990-BDDA9F62-1B1C-410E-8C27-930C3C6E3105Q34531091-D85914B4-5204-4FBD-8B0B-A4E89DAF1E07Q34654463-4EE774B8-734C-47DE-976E-5F75B44C3F56Q34680671-10C519AF-C3A5-4E98-A7CE-E0F6158A8B30Q35067624-DE01AB07-DE8D-4D8E-9603-332306875907Q35663577-48610685-7C9B-4B82-B360-B9221DA624F5Q35807946-F5F85623-D498-40B7-9DE0-7635CB11864AQ35848297-EA8851F9-B0F5-4502-A35B-85C5BA1F22FEQ35852871-A57B5BD0-BCBD-403B-AAD5-8FA2A09BA266Q35943224-3A16CDB7-80B5-4737-8979-139B0433A0D8Q36335465-9E2505F4-7110-4167-A0C1-DF6E92E3F2AAQ36583985-78D61AC1-DA92-446C-B2D5-25A9A394CC3DQ36605522-4AAB895B-F1CA-4EE0-973C-85C5A526BEBDQ36887407-66CD3B82-DEAB-4581-878A-7BF23CC17080Q36887721-A5D08330-9632-4B69-AC8E-74BCCA7790E9Q36906094-3829128D-2106-4581-9DA3-C89EA7F74367Q36907188-8B27C2A6-26A1-4B67-A413-A0900A08808EQ37153781-3E3D02E9-3116-4C8C-880D-7363DF0D7188Q37328598-96A5DF2F-9AAC-4A26-8306-1905E5527554Q37720098-2FFD094B-4ABD-4756-B83B-9E06B5E01191Q39051286-7488A34F-8693-44FE-9849-796B36C8C329Q39118597-46AFABC4-62A5-4D43-9DD1-44D4AB8E89D5Q40978947-59C93629-DFCC-41D4-995B-8EA2B71D2A1CQ42364886-C789F88C-89FC-47AA-840F-3DF369816317Q47131381-5E0F13E8-05B1-4848-956D-958A3B60586EQ47159555-A62513DF-A775-4146-9E8F-3387DD967624Q55094487-B2F8881C-4B44-47B6-A03D-4F306A5092BBQ57018188-FF5D62B0-05E6-4A48-85DC-55B32BD6349F
P2860
Recent advances in non-small cell lung cancer biology and clinical management.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recent advances in non-small cell lung cancer biology and clinical management.
@en
type
label
Recent advances in non-small cell lung cancer biology and clinical management.
@en
prefLabel
Recent advances in non-small cell lung cancer biology and clinical management.
@en
P1433
P1476
Recent advances in non-small cell lung cancer biology and clinical management
@en
P2093
Jan A Burger
P304
P577
2012-04-01T00:00:00Z